Table 1.
Genetic, Biochemical, and Clinical Findings in Individuals with ELAC2 Mutations
| ID | Sex |
OXPHOS Activities and RNA Processing |
||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
ELAC2 Mutations |
RCC | % of Lowest Control | Absolute Values | Reference Range |
Mean x-Fold Accumulation of Unprocessed RNA Intermediates |
Clinical Features |
||||||
| cDNA (NM_018127.6) and Protein (NP_060597) | Muscle | Fibroblasts | AO | Course | HCM | Other Features | ||||||
| #61525a | male | c.[631C>T; 1559C>T], p.[Arg211∗; Thr520Ile] | NA | NA | NA | 4 months | death at 6 months | yes | intrauterine growth retardation, lactic acidosis, myocardial damage and necrosis associated with acute cardiac failure | |||
| #57415a,b | male | c.[631C>T; 1559C>T], p.[Arg211∗; Thr520Ile] | I II II+III IV |
50% normal normal normal |
0.07 0.29 0.46 1.07 |
(0.14–0.35) (0.18–0.41) (0.30–0.67) (0.91–2.24) |
167 | 10.6 | 3 months | alive at 2 years, 10 months | yes | psychomotor and growth retardation, muscular hypotonia, microcephaly, dysphagia, lactic acidosis, sensorineural hearing impairment, hyperintensities in basal ganglia at age 3 months |
| #61982b | female | c.[460T>C; 460T>C], p.[Phe154Leu; Phe154Leu] | I II II+III IV |
60% ND normal normal |
0.062 ND 0.085 0.021 |
(0.104–0.268) ND (0.040–0.204) (0.014–0.034) |
NA | 10.5 | 2 months | death at 11 months | yes | intrauterine growth retardation, lactic acidosis, cardiac failure, normal muscle biopsy findings |
| #36355a | female | c.[1267C>T; 1267C>T], p.[Leu423Phe; Leu423Phe] | I II II+III IV |
82% ND 100% 78% |
0.14 ND 0.08 0.70 |
(0.17–0.56) ND (0.08–0.45) (0.90–4.70) |
NA | NA | 5 months | alive at 13 years | yes | mild psychomotor delay, muscular hypotonia |
| #65937a | female | c.[1267C>T; 1267C>T], p.[Leu423Phe; Leu423Phe] | I II II+III IV |
86% 100% normal normal |
0.12 0.18 0.32 1.61 |
(0.14–0.35) (0.18–0.41) (0.30–0.67) (0.91–2.24) |
30 | 2.6 | 5 months | death at 4 years, 9 months | yes later DCM | psychomotor retardation, muscular hypotonia, cardiac failure, COX-deficient fibers |
Mitochondrial respiratory chain complexes (RCC) in muscle: I, NADH-CoQ-oxidoreductase; II, succinate dehydrogenase; II+III, succinate cytochrome c oxidoreductase; IV/COX, cytochrome c oxidase. Enzyme activities were determined in muscle biopsies and normalized to citrate synthase (CS). Absolute values and reference ranges are given in [mU/mU CS]. Abbreviations are as follows: AO, age of onset; HCM, hypertrophic cardiomyopathy; DCM, dilated cardiomyopathy; NA, no material available; ND, not determined.
These individuals are siblings.
Investigated by exome sequencing.